Cochlear nerve fiber

**Cochlear nerve fibers** are the axonal extensions of bipolar (type I) and unipolar (type II) neurons whose cell bodies form the spiral ganglion within the cochlea of the inner ear. These nerve fibers receive input from the mechanosensory hair cells of the organ of Corti and carry electrical impulses (action potentials) through the cochlear nerve (a division of cranial nerve VIII, the vestibulocochlear nerve) to the cochlear nuclei of the brainstem, where auditory processing begins. The majority of cochlear nerve fibers are type I, which are large, myelinated, and innervate inner hair cells, while type II fibers are small, unmyelinated, and innervate outer hair cells. Cochlear nerve fibers are essential for normal hearing, and their dysfunction or loss underlies several forms of sensorineural hearing loss, but they are not considered classical molecular drug targets such as receptors or enzymes[1][2][3][4]. **Key notes:** - The query is *incorrect as a drug target*: "Cochlear/auditory nerve fibers" refers to anatomical nerve fiber bundles, not a molecule, receptor, transporter, channel, or other canonical drug target. They are often the *recipient* of therapy (e.g., electric stimulation by cochlear implants for hearing restoration), but not therapeutically targeted by conventional drugs[1][2][3]. - No canonical abbreviation exists—"cochlear nerve" is preferred in anatomy. - No interacting drugs or mechanisms of action per conventional pharmacology. - No protein or other molecule-based biomarkers specific to these fibers; status is evaluated through functional or electrophysiological testing, not molecular markers[3][4].

Other names

Cochlear nerveAuditory nerve fiberAcoustic nerve fiberSpiral ganglion neuronAuditory afferent fiber